Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.

Mourikis TP, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, Cereda M, Lagergren J, Howell M, Yau C, Fitzgerald RC, Scaffidi P; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Ciccarelli FD.

Nat Commun. 2019 Jul 15;10(1):3101. doi: 10.1038/s41467-019-10898-3.

PMID:
31308377
2.

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Bornschein J, Wernisch L, Secrier M, Miremadi A, Perner J, MacRae S, O'Donovan M, Newton R, Menon S, Bower L, Eldridge MD, Devonshire G, Cheah C, Turkington R, Hardwick RH, Selgrad M, Venerito M, Malfertheiner P; OCCAMS Consortium, Fitzgerald RC.

Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32384. [Epub ahead of print]

PMID:
31050820
3.

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.

Turkington RC, Knight LA, Blayney JK, Secrier M, Douglas R, Parkes EE, Sutton EK, Stevenson L, McManus D, Halliday S, McCavigan AM, Logan GE, Walker SM, Steele CJ, Perner J, Bornschein J, MacRae S, Miremadi A, McCarron E, McQuaid S, Arthur K, James JA, Eatock MM, O'Neill R, Noble F, Underwood TJ, Harkin DP, Salto-Tellez M, Fitzgerald RC, Kennedy RD; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group.

Gut. 2019 Mar 9. pii: gutjnl-2018-317624. doi: 10.1136/gutjnl-2018-317624. [Epub ahead of print]

4.

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.

Frankell AM, Jammula S, Li X, Contino G, Killcoyne S, Abbas S, Perner J, Bower L, Devonshire G, Ococks E, Grehan N, Mok J, O'Donovan M, MacRae S, Eldridge MD, Tavaré S; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Fitzgerald RC.

Nat Genet. 2019 Mar;51(3):506-516. doi: 10.1038/s41588-018-0331-5. Epub 2019 Feb 4.

PMID:
30718927
5.

Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.

Garcia E, Hayden A, Birts C, Britton E, Rogerson C, Bleaney CW, Cowie A, Pickard K, Mellone M, Choh C, Derouet M, Duriez P, Noble F, White MJ, Primrose JN, Strefford JC, Rose-Zerilli M, Thomas GJ, Ang Y, Sharrocks AD, Fitzgerald RC, Underwood TJ; OCCAMS consortium.

Sci Rep. 2019 Jan 22;9(1):318. doi: 10.1038/s41598-018-37591-7.

6.

Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.

Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA; OCCAMS Consortium.

Gastroenterology. 2018 Dec;155(6):1720-1728.e4. doi: 10.1053/j.gastro.2018.08.036. Epub 2018 Aug 27.

7.

Stroboscopic Vision When Interacting With Multiple Moving Objects: Perturbation Is Not the Same as Elimination.

Bennett SJ, Hayes SJ, Uji M.

Front Psychol. 2018 Jul 25;9:1290. doi: 10.3389/fpsyg.2018.01290. eCollection 2018.

8.

Evolutionary history of human colitis-associated colorectal cancer.

Baker AM, Cross W, Curtius K, Al Bakir I, Choi CR, Davis HL, Temko D, Biswas S, Martinez P, Williams MJ, Lindsay JO, Feakins R, Vega R, Hayes SJ, Tomlinson IPM, McDonald SAC, Moorghen M, Silver A, East JE, Wright NA, Wang LM, Rodriguez-Justo M, Jansen M, Hart AL, Leedham SJ, Graham TA.

Gut. 2019 Jun;68(6):985-995. doi: 10.1136/gutjnl-2018-316191. Epub 2018 Jul 10.

9.

Atypical biological kinematics are represented during observational practice.

Foster NC, Bennett SJ, Causer J, Bird G, Andrew M, Hayes SJ.

J Exp Psychol Hum Percept Perform. 2018 Jun;44(6):842-847. doi: 10.1037/xhp0000516.

PMID:
29809051
10.

Sensorimotor learning and associated visual perception are intact but unrelated in autism spectrum disorder.

Hayes SJ, Andrew M, Foster NC, Elliott D, Gowen E, Bennett SJ.

Autism Res. 2018 Feb;11(2):296-304. doi: 10.1002/aur.1882. Epub 2017 Oct 20.

PMID:
29052364
11.

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.

Noble F, Lloyd MA, Turkington R, Griffiths E, O'Donovan M, O'Neill JR, Mercer S, Parsons SL, Fitzgerald RC, Underwood TJ; OCCAMS consortium.

Br J Surg. 2017 Dec;104(13):1816-1828. doi: 10.1002/bjs.10627. Epub 2017 Sep 25.

12.

Impression or expression? The influence of self-monitoring on the social modulation of motor contagion.

Roberts JW, Bennett SJ, Hayes SJ.

Q J Exp Psychol (Hove). 2018 Apr;71(4):850-858. doi: 10.1080/17470218.2017.1307430. Epub 2018 Jan 1.

PMID:
28856949
13.

A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Noorani A, Bornschein J, Lynch AG, Secrier M, Achilleos A, Eldridge M, Bower L, Weaver JMJ, Crawte J, Ong CA, Shannon N, MacRae S, Grehan N, Nutzinger B, O'Donovan M, Hardwick R, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium.

Genome Res. 2017 Jun;27(6):902-912. doi: 10.1101/gr.214296.116. Epub 2017 May 2. Erratum in: Genome Res. 2017 Oct;27(10 ):1782.

14.

The multiple process model of goal-directed reaching revisited.

Elliott D, Lyons J, Hayes SJ, Burkitt JJ, Roberts JW, Grierson LE, Hansen S, Bennett SJ.

Neurosci Biobehav Rev. 2017 Jan;72:95-110. doi: 10.1016/j.neubiorev.2016.11.016. Epub 2016 Nov 25. Review.

PMID:
27894830
15.

Quiet eye facilitates sensorimotor preprograming and online control of precision aiming in golf putting.

Causer J, Hayes SJ, Hooper JM, Bennett SJ.

Cogn Process. 2017 Feb;18(1):47-54. doi: 10.1007/s10339-016-0783-4. Epub 2016 Nov 7.

16.

Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.

Garcia E, Hayden A, Birts C, Britton E, Cowie A, Pickard K, Mellone M, Choh C, Derouet M, Duriez P, Noble F, White MJ, Primrose JN, Strefford JC, Rose-Zerilli M, Thomas GJ, Ang Y, Sharrocks AD, Fitzgerald RC, Underwood TJ; OCCAMS consortium.

Sci Rep. 2016 Sep 7;6:32417. doi: 10.1038/srep32417. Erratum in: Sci Rep. 2019 Jan 22;9(1):318.

17.

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, Yang TP, Bower L, Chettouh H, Crawte J, Galeano-Dalmau N, Grabowska A, Saunders J, Underwood T, Waddell N, Barbour AP, Nutzinger B, Achilleos A, Edwards PA, Lynch AG, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium.

Nat Genet. 2016 Oct;48(10):1131-41. doi: 10.1038/ng.3659. Epub 2016 Sep 5. Erratum in: Nat Genet. 2017 Jan 31;49(2):317.

18.

Complimentary lower-level and higher-order systems underpin imitation learning.

Andrew M, Bennett SJ, Elliott D, Hayes SJ.

Brain Cogn. 2016 Apr;104:25-33. doi: 10.1016/j.bandc.2016.02.001. Epub 2016 Feb 18.

PMID:
26897261
19.

The influence of environmental context in interpersonal observation-execution.

Roberts JW, Bennett SJ, Welsh TN, Elliott D, Lyons JL, Hayes SJ.

Q J Exp Psychol (Hove). 2017 Jan;70(1):154-162. doi: 10.1080/17470218.2015.1127982.

PMID:
26731164
20.

Common vs. independent limb control in sequential vertical aiming: The cost of potential errors during extensions and reversals.

Roberts JW, Elliott D, Lyons JL, Hayes SJ, Bennett SJ.

Acta Psychol (Amst). 2016 Jan;163:27-37. doi: 10.1016/j.actpsy.2015.10.004. Epub 2015 Nov 18.

PMID:
26590702

Supplemental Content

Loading ...
Support Center